Genocea Biosciences Inc
NASDAQ:GNCA
Income Statement
Earnings Waterfall
Genocea Biosciences Inc
Revenue
|
1.9m
USD
|
Operating Expenses
|
-57.4m
USD
|
Operating Income
|
-55.4m
USD
|
Other Expenses
|
18.3m
USD
|
Net Income
|
-37.2m
USD
|
Income Statement
Genocea Biosciences Inc
Dec-2021 | Mar-2022 | ||
---|---|---|---|
Revenue | |||
Revenue |
2
N/A
|
2
+16%
|
|
Operating Income | |||
Operating Expenses |
(54)
|
(57)
|
|
Selling, General & Administrative |
(15)
|
(15)
|
|
Research & Development |
(39)
|
(43)
|
|
Operating Income |
(52)
N/A
|
(55)
-6%
|
|
Pre-Tax Income | |||
Interest Income Expense |
19
|
18
|
|
Total Other Income |
(0)
|
0
|
|
Pre-Tax Income |
(33)
N/A
|
(37)
-12%
|
|
Net Income | |||
Income from Continuing Operations |
(33)
|
(37)
|
|
Net Income (Common) |
(33)
N/A
|
(37)
-12%
|
|
EPS (Diluted) |
-0.47
N/A
|
-0.52
-11%
|